Insider Trading & Ownership of TROY EDWARD WILSON

Location: San Diego, CA
Summary: The estimated net worth of TROY EDWARD WILSON is at least $9,220,790 dollars as of 06 Jan 2026. TROY EDWARD WILSON is the President and CEO, Director of Kura Oncology, Inc. and owns shares of Kura Oncology, Inc. (KURA) stock worth about $5.69M. TROY EDWARD WILSON is the Director of Avidity Biosciences, Inc. and owns shares of Avidity Biosciences, Inc. (RNA) stock worth about $3.38M. TROY EDWARD WILSON is the Director of PUMA BIOTECHNOLOGY, INC. and owns shares of PUMA BIOTECHNOLOGY, INC. (PBYI) stock worth about $149.7K.
Signature: Teresa Bair, Attorney-in-fact for Troy E. Wilson
All Insider Reports: All Insider Reports

Notify me when TROY EDWARD WILSON files a new Insider Trading report.

Ownership of TROY EDWARD WILSON

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
KURA	Kura Oncology, Inc.	President and CEO, Director	$5,694,155	+$385,928	+7.3%	02 Jan 2026
RNA	Avidity Biosciences, Inc.	Director	$3,376,910	-$5,752,430	-63%	05 Sep 2025
PBYI	PUMA BIOTECHNOLOGY, INC.	Director	$149,725	-$36,720	-20%	13 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.